Recap: 5th Global Forum on TB Vaccines
The 5th Global Forum on TB Vaccines took place February 20-23, 2018 in New Delhi, India. Aeras was delighted to join stakeholders from across the field of TB vaccine research and development – including academic researchers, bio-pharma partners, funders, policymakers and advocates—to share findings and help promote a global dialogue on the state of this field.
The conference was packed with exciting plenaries, presentations and poster sessions. Aeras was involved in many of these events, and had the opportunity to announce our latest clinical trial results.
The keynote address was given by Professor Barry Bloom, a Joan L. and Julius H. Jacobson Research Professor of Public Health at Harvard University and member of the Aeras Board of Directors. He emphasized “Vaccine trials either work or fail. Vaccine research does not fail. We always learn from the research…The only vaccines studies which fail are those from which we fail to learn.”
At the plenary session on Increasing Probability of Success and Maximizing Impact, Aeras Chief Medical Officer Ann Ginsberg discussed enriching cohorts for smaller, quicker and more efficient TB vaccine studies on behalf of Aeras Senior Clinical Director Dereck Tait. The next day, Dr. Ginsberg also provided an overview of progress in the TB vaccine clinical development pipeline.
At the final plenary session, Aeras CEO Jacqueline Shea joined experts in the roundtable discussion on Partnering for Progress and Innovation. She expressed that it’s “an enormously exciting time for TB vaccines” and “our challenge over the next 2 years is how do we seize and build on the momentum we’re seeing from this Forum.”
Site Visit to Operation ASHA
The final day of the Global Forum offered attendees the chance to participate in site visits to local institutions working on TB research and care. Agnes Chenine, a Senior Scientist at Aeras, wrote about her visit to Operation ASHA, a nonprofit organization that provides TB treatment and health services to underserved populations in India.
Overall, the Fifth Global Forum succeeded in bringing together stakeholders from the field of TB vaccine research and development, and Aeras looks forward to continued progress in the path forward to eliminating TB.